10-68906820-T-C

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_024045.2(DDX50):ā€‹c.197T>Cā€‹(p.Met66Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,460 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 0.0000027 ( 0 hom. )

Consequence

DDX50
NM_024045.2 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.110
Variant links:
Genes affected
DDX50 (HGNC:17906): (DExD-box helicase 50) DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of this DEAD box protein family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. This gene encodes a DEAD box enzyme that may be involved in ribosomal RNA synthesis or processing. This gene and DDX21, also called RH-II/GuA, have similar genomic structures and are in tandem orientation on chromosome 10, suggesting that the two genes arose by gene duplication in evolution. This gene has pseudogenes on chromosomes 2, 3 and 4. Alternative splicing of this gene generates multiple transcript variants, but the full length nature of all the other variants but one has not been defined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.047456622).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DDX50NM_024045.2 linkuse as main transcriptc.197T>C p.Met66Thr missense_variant 2/15 ENST00000373585.8 NP_076950.1 Q9BQ39
DDX50XM_011540144.3 linkuse as main transcriptc.2T>C p.Met1? start_lost 3/16 XP_011538446.1
DDX50XM_047425726.1 linkuse as main transcriptc.2T>C p.Met1? start_lost 2/15 XP_047281682.1
DDX50XM_047425727.1 linkuse as main transcriptc.2T>C p.Met1? start_lost 2/15 XP_047281683.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DDX50ENST00000373585.8 linkuse as main transcriptc.197T>C p.Met66Thr missense_variant 2/151 NM_024045.2 ENSP00000362687.3 Q9BQ39

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.00000797
AC:
2
AN:
250812
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
135568
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000274
AC:
4
AN:
1461460
Hom.:
0
Cov.:
31
AF XY:
0.00000275
AC XY:
2
AN XY:
727022
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000360
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 22, 2023The c.197T>C (p.M66T) alteration is located in exon 2 (coding exon 2) of the DDX50 gene. This alteration results from a T to C substitution at nucleotide position 197, causing the methionine (M) at amino acid position 66 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
11
DANN
Benign
0.82
DEOGEN2
Benign
0.038
T;T
Eigen
Benign
-0.59
Eigen_PC
Benign
-0.41
FATHMM_MKL
Benign
0.58
D
LIST_S2
Benign
0.41
T;T
M_CAP
Benign
0.0026
T
MetaRNN
Benign
0.047
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N;.
PrimateAI
Benign
0.45
T
PROVEAN
Benign
0.0
N;.
REVEL
Benign
0.045
Sift
Benign
0.35
T;.
Sift4G
Benign
0.30
T;T
Polyphen
0.0060
B;.
Vest4
0.13
MutPred
0.20
Gain of phosphorylation at M66 (P = 0.0101);.;
MVP
0.26
MPC
0.58
ClinPred
0.028
T
GERP RS
1.3
Varity_R
0.039
gMVP
0.090

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1444839814; hg19: chr10-70666576; API